3/20/2024 | HY | Market Commentary: Medline, Miter price; secondary firm post-Fed; Crescent Energy adds; Altice crumbles post-earnings
|
3/20/2024 | CLHY | Market Commentary: Vistra Zero, Entegris, Southern Veterinary break; Miter, Medline, Beacon updated
|
3/20/2024 | HY | New Issue: Medline sells $1 billion five-year secured notes at par to yield 6¼%
|
3/20/2024 | HY | Medline talks $1 billion five-year secured notes at 6¼% area yield; pricing Wednesday
|
3/19/2024 | HY | Market Commentary: Domestic junk market prices $1 billion; Medline joins calendar, existing notes rise
|
3/19/2024 | BKDDHY | S&P gives B+ to Medline notes
|
3/19/2024 | BKDDHY | Moody’s rates Medline notes B1
|
3/19/2024 | HY | Medline to price $1 billion five-year secured notes on Wednesday; initial talk mid-6% area
|
3/19/2024 | BKDDHY | Fitch assigns Medline notes BB-'
|
3/14/2024 | CLHY | Market Commentary: LifePoint, Koppers, AZZ, Air Canada break; SunSource, Chefs’ Warehouse, Iridium revised
|
3/14/2024 | BKHY | S&P assigns B+ to Medline loan
|
11/17/2023 | BKDDHY | Fitch revises Medline outlook to stable
|
5/23/2022 | HY | Market Commentary: Morning Commentary: Junk opens week stronger; athenahealth, Medline bonds trade higher
|
4/21/2022 | BKDDHY | Fitch revises Medline view to negative
|
12/31/2021 | HY | Market Commentary: Outlook 2022: Junk issuance to moderate; expected $325 billion to $435 billion in year ahead
|
9/29/2021 | HY | Medline rejiggers buyout financing, shifting proceeds to secured notes and loans, sets price talk
|
9/27/2021 | BKDDHY | Moody's assigns Medline B1
|
9/27/2021 | HY | Roadshow starts for $7.77 billion two-part high-yield notes backing buyout of Medline
|